We are live on ! Find out more
HPCM

High Pointe Capital Management Portfolio holdings

AUM $139M
1-Year Est. Return 24.99%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
–
AUM
$70.1M
AUM Growth
-$2.65M
Cap. Flow
-$4.75M
Cap. Flow %
-6.77%
Top 10 Hldgs %
26.21%
Holding
92
New
5
Increased
4
Reduced
38
Closed
11

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$782K
2
SRCL
Stericycle Inc
SRCL
+$582K
3
AZN icon
AstraZeneca
AZN
+$493K
4
QCOM icon
Qualcomm
QCOM
+$397K
5
NVO
Novo Nordisk
NVO
+$352K

Top Sells

Rank Stock Value
1
JLL icon
Jones Lang LaSalle
JLL
+$1.34M
2
SBUX icon
Starbucks
SBUX
+$1.28M
3
SRE icon
Sempra
SRE
+$1.15M
4
ZTS icon
Zoetis
ZTS
+$1M
5
AAPL icon
Apple
AAPL
+$819K

Sector Composition

Rank Sector Weight
1 Healthcare 20.02%
2 Financials 18.24%
3 Technology 11.59%
4 Communication Services 9.9%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAC icon
1
Bank of America
BAC
$429B
$2.14M 3.05%
75,910
-240
-0.3% -$7.16K
JPM icon
2
JPMorgan Chase
JPM
$916B
$2.09M 2.98%
20,090
– –
TJX icon
3
TJX Companies
TJX
$179B
$2.04M 2.91%
42,960
-220
-0.5% -$9.66K
WFC icon
4
Wells Fargo
WFC
$254B
$2M 2.86%
36,140
-130
-0.4% -$6.96K
C icon
5
Citigroup
C
$213B
$1.8M 2.57%
26,930
-100
-0.4% -$6.88K
UNP icon
6
Union Pacific
UNP
$174B
$1.76M 2.51%
12,410
-80
-0.6% -$11.2K
CVS icon
7
CVS Health
CVS
$135B
$1.68M 2.39%
26,070
-120
-0.5% -$7.91K
CSCO icon
8
Cisco
CSCO
$443B
$1.66M 2.36%
38,470
– –
APC
9
DELISTED
Anadarko Petroleum
APC
$1.64M 2.34%
22,380
-120
-0.5% -$8.13K
FDX icon
10
FedEx
FDX
$73B
$1.57M 2.24%
6,920
-40
-0.6% -$9.91K
MDT icon
11
Medtronic
MDT
$112B
$1.53M 2.18%
17,870
– –
SLB icon
12
SLB Ltd
SLB
$72.7B
$1.5M 2.14%
22,431
+1,790
+9% +$123K
GOOG icon
13
Alphabet (Google) Class C
GOOG
$4.11T
$1.5M 2.13%
26,820
-1,400
-5% -$75.6K
BSX icon
14
Boston Scientific
BSX
$68.4B
$1.5M 2.13%
45,710
– –
BMY icon
15
Bristol-Myers Squibb
BMY
$129B
$1.47M 2.09%
26,466
-140
-0.5% -$7.56K
CE icon
16
Celanese
CE
$4.82B
$1.42M 2.03%
12,820
-90
-0.7% -$9.93K
NOV icon
17
NOV
NOV
$6.84B
$1.39M 1.99%
32,100
+2,760
+9% +$112K
CVX icon
18
Chevron
CVX
$382B
$1.36M 1.94%
10,780
– –
HPE icon
19
Hewlett Packard
HPE
$58.8B
$1.34M 1.91%
91,480
-480
-0.5% -$7.96K
MA icon
20
Mastercard
MA
$498B
$1.32M 1.88%
6,700
-150
-2% -$28.2K
J icon
21
Jacobs Solutions
J
$16B
$1.28M 1.82%
24,379
-157
-0.6% -$8.07K
QCOM icon
22
Qualcomm
QCOM
$164B
$1.27M 1.8%
22,560
+7,110
+46% +$397K
CMCSA icon
23
Comcast
CMCSA
$87.3B
$1.26M 1.8%
38,490
– –
CNC icon
24
Centene
CNC
$30.5B
$1.25M 1.78%
20,320
– –
LVS icon
25
Las Vegas Sands
LVS
$31.4B
$1.25M 1.77%
16,300
-140
-0.9% -$10.7K
1
2 3 4

Similar funds

COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
TC
Tatro Capital Lexington, Kentucky $134M AUM 3.29% 1-Year Est. Return
FFA
Freedman Financial Associates Peabody, Massachusetts $145M AUM 6.97% 1-Year Est. Return
NWM
Nauset Wealth Management Westport, Connecticut $126M AUM
KCA
Karn Couzens & Associates Farmington, Connecticut $157M AUM 11.36% 1-Year Est. Return
RCM
RVB Capital Management Great Neck, New York $117M AUM 17.05% 1-Year Est. Return
SIS
SVB Investment Services Salt Lake City, Utah $161M AUM 4.97% 1-Year Est. Return
MWM
Midwest Wealth Management Indianapolis, Indiana $165M AUM 19.98% 1-Year Est. Return

High Pointe Capital Management's Q2 2018 Portfolio in Review

As of Q2 2018, High Pointe Capital Management held 92 positions worth $70.1M, down 3.6% from $72.8M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

High Pointe Capital Management withdrew a net $4.75M in Q2 2018, closing 11 positions and reducing 38 holdings. Its most notable exit was Jones Lang LaSalle, an estimated $1.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Financials and Technology.

Against the trend, High Pointe Capital Management opened a new position in Regeneron Pharmaceuticals worth $862K.

  • High Pointe Capital Management's largest Q2 2018 buy was Regeneron Pharmaceuticals: 2,500 shares worth $862K.
  • High Pointe Capital Management added most to AstraZeneca in Q2 2018, an estimated $493K increase.
  • High Pointe Capital Management's biggest Q2 2018 reduction was Alphabet (Google) Class C, cutting an estimated $75.6K.
  • High Pointe Capital Management fully exited Jones Lang LaSalle in Q2 2018, selling an estimated $1.34M.
  • High Pointe Capital Management's ten largest holdings make up 26% of its $70.1M portfolio in Q2 2018.
  • High Pointe Capital Management opened 5 new positions and closed 11 in Q2 2018.
  • High Pointe Capital Management's portfolio value fell 3.6% quarter-over-quarter to $70.1M.

Based on High Pointe Capital Management's 13F filing for Q2 2018, filed 8 Aug 2018.